These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1501702)

  • 1. French increase ties with industry but researchers still face hurdles.
    Butler D
    Nature; 1992 Aug; 358(6387):531. PubMed ID: 1501702
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS scandal indicts French government.
    Anderson C
    Nature; 1991 Sep; 353(6341):197. PubMed ID: 1896063
    [No Abstract]   [Full Text] [Related]  

  • 3. German agencies sound alarm on risks of broad gene patents...as spending goes up for research.
    Schiermeier Q
    Nature; 2000 Jul; 406(6792):111. PubMed ID: 10910319
    [No Abstract]   [Full Text] [Related]  

  • 4. Pasteur takes US company to court.
    Coles P
    Nature; 1988 May; 333(6170):196. PubMed ID: 3367991
    [No Abstract]   [Full Text] [Related]  

  • 5. [The National Agency for Research on AIDS].
    Levy JP
    Ann Med Interne (Paris); 1990; 141(2):169-70. PubMed ID: 2353757
    [No Abstract]   [Full Text] [Related]  

  • 6. Proprietary rights and the norms of science in biotechnology research.
    Eisenberg RS
    Yale Law J; 1987 Dec; 97(2):177-231. PubMed ID: 11660398
    [No Abstract]   [Full Text] [Related]  

  • 7. US rejects French request to reopen AIDS patent deal.
    Anderson C; Butler D
    Nature; 1992 Sep; 359(6393):262. PubMed ID: 1406920
    [No Abstract]   [Full Text] [Related]  

  • 8. French researchers face winter of discontent.
    Vermij P
    Nat Med; 2004 Apr; 10(4):319. PubMed ID: 15057207
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of stem cells in biomedical research. Biotechnology Industry Organization (BIO) position statement.
    Biotechnology Industry Organization
    J Biolaw Bus; 1999; 3(1):40-4. PubMed ID: 11933970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Last hurdle cleared before US-French AIDS accord.
    Nature; 1987 Mar 26-Apr 1; 326(6111):318. PubMed ID: 3470600
    [No Abstract]   [Full Text] [Related]  

  • 11. Razing the tollbooths. A call for restricting patents on basic biomedical research.
    Stix G
    Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
    [No Abstract]   [Full Text] [Related]  

  • 12. Washington Insider: Congressional impasse on human cloning.
    Doerflinger RM
    Natl Cathol Bioeth Q; 2004; 4(1):19-25. PubMed ID: 15192847
    [No Abstract]   [Full Text] [Related]  

  • 13. New law to boost French biotech industry.
    Louët S
    Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900
    [No Abstract]   [Full Text] [Related]  

  • 14. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 15. University-industry collaboration. Last of the big-time spenders?
    Lawler A
    Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
    [No Abstract]   [Full Text] [Related]  

  • 16. Again, army shuns AIDS peer review.
    Science; 1994 Oct; 266(5183):207. PubMed ID: 7939648
    [No Abstract]   [Full Text] [Related]  

  • 17. Franco-US agreement on AIDS test within sight.
    Palca J
    Nature; 1987 Mar 12-18; 326(6109):115. PubMed ID: 3821879
    [No Abstract]   [Full Text] [Related]  

  • 18. Going beyond the native: protecting DNA and protein patents.
    Chahine KG
    Nat Biotechnol; 1997 Feb; 15(2):183-6. PubMed ID: 9035147
    [No Abstract]   [Full Text] [Related]  

  • 19. The 1992 biotechnology agenda: a message for candidates Bush and Clinton.
    Duzan SA
    Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052
    [No Abstract]   [Full Text] [Related]  

  • 20. Industry-sponsored research and consultation.
    J Med Educ; 1978 Jul; 53(7):610-1. PubMed ID: 671511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.